{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T16:19:52Z","timestamp":1780589992119,"version":"3.54.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T00:00:00Z","timestamp":1533254400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T00:00:00Z","timestamp":1533254400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["1K08AR064834 and R03AR068094"],"award-info":[{"award-number":["1K08AR064834 and R03AR068094"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13075-018-1655-3","type":"journal-article","created":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T13:16:12Z","timestamp":1533302172000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Serum metabolomic profiling predicts synovial gene expression in rheumatoid arthritis"],"prefix":"10.1186","volume":"20","author":[{"given":"Rekha","family":"Narasimhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana","family":"Coras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara B.","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon R.","family":"Sweeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Lodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Tiziani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Boyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Kavanaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1951-9411","authenticated-orcid":false,"given":"Monica","family":"Guma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,3]]},"reference":[{"issue":"8","key":"1655_CR1","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nrrheum.2017.115","volume":"13","author":"C Orr","year":"2017","unstructured":"Orr C, Vieira-Sousa E, Boyle DL, Buch MH, Buckley CD, Canete JD, et al. Synovial tissue research: a state-of-the-art review. Nat Rev Rheumatol. 2017;13(8):463\u201375.","journal-title":"Nat Rev Rheumatol"},{"key":"1655_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2174\/1874312901105010115","volume":"5","author":"E Vieira-Sousa","year":"2011","unstructured":"Vieira-Sousa E, Gerlag DM, Tak PP. Synovial tissue response to treatment in rheumatoid arthritis. Open Rheumatol J. 2011;5:115\u201322.","journal-title":"Open Rheumatol J"},{"issue":"3","key":"1655_CR3","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1136\/ard.2007.074229","volume":"67","author":"A Kavanaugh","year":"2008","unstructured":"Kavanaugh A, Rosengren S, Lee SJ, Hammaker D, Firestein GS, Kalunian K, et al. Assessment of rituximab's immunomodulatory synovial effects (ARISE trial). 1: clinical and synovial biomarker results. Ann Rheum Dis. 2008;67(3):402\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"1655_CR4","doi-asserted-by":"publisher","first-page":"R90","DOI":"10.1186\/ar4555","volume":"16","author":"G Dennis Jr","year":"2014","unstructured":"Dennis G Jr, Holweg CT, Kummerfeld SK, Choy DF, Setiadi AF, Hackney JA, et al. Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics. Arthritis Res Ther. 2014;16(2):R90.","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"1655_CR5","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1136\/annrheumdis-2013-204603","volume":"74","author":"S Kelly","year":"2015","unstructured":"Kelly S, Humby F, Filer A, Ng N, Di Cicco M, Hands RE, et al. Ultrasound-guided synovial biopsy: a safe, well-tolerated and reliable technique for obtaining high-quality synovial tissue from both large and small joints in early arthritis patients. Ann Rheum Dis. 2015;74(3):611\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"17","key":"1655_CR6","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.2174\/1381612821666150310145758","volume":"21","author":"E Astorri","year":"2015","unstructured":"Astorri E, Nerviani A, Bombardieri M, Pitzalis C. Towards a stratified targeted approach with biologic treatments in rheumatoid arthritis: role of synovial pathobiology. Curr Pharm Des. 2015;21(17):2216\u201324.","journal-title":"Curr Pharm Des"},{"issue":"3","key":"1655_CR7","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/BOR.0b013e32835fd8eb","volume":"25","author":"C Pitzalis","year":"2013","unstructured":"Pitzalis C, Kelly S, Humby F. New learnings on the pathophysiology of RA from synovial biopsies. Curr Opin Rheumatol. 2013;25(3):334\u201344.","journal-title":"Curr Opin Rheumatol"},{"key":"1655_CR8","first-page":"545493","volume":"2014","author":"A Burska","year":"2014","unstructured":"Burska A, Boissinot M, Ponchel F. Cytokines as biomarkers in rheumatoid arthritis. Mediat Inflamm. 2014;2014:545493.","journal-title":"Mediat Inflamm"},{"issue":"2","key":"1655_CR9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/tpj.2013.48","volume":"14","author":"AN Burska","year":"2014","unstructured":"Burska AN, Roget K, Blits M, Soto Gomez L, van de Loo F, Hazelwood LD, et al. Gene expression analysis in RA: towards personalized medicine. Pharmacogenomics J. 2014;14(2):93\u2013106.","journal-title":"Pharmacogenomics J"},{"issue":"3","key":"1655_CR10","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/j.1752-8062.2011.00388.x","volume":"5","author":"AD Eckhart","year":"2012","unstructured":"Eckhart AD, Beebe K, Milburn M. Metabolomics as a key integrator for \u201comic\u201d advancement of personalized medicine and future therapies. Clin Transl Sci. 2012;5(3):285\u20138.","journal-title":"Clin Transl Sci"},{"issue":"4","key":"1655_CR11","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nrm3314","volume":"13","author":"GJ Patti","year":"2012","unstructured":"Patti GJ, Yanes O, Siuzdak G. Innovation: metabolomics: the apogee of the omics trilogy. Nat Rev Mol Cell Biol. 2012;13(4):263\u20139.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"1655_CR12","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1136\/annrheumdis-2014-206618","volume":"74","author":"L Semerano","year":"2015","unstructured":"Semerano L, Romeo PH, Boissier MC. Metabolomics for rheumatic diseases: has the time come? Ann Rheum Dis. 2015;74(7):1325\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"1655_CR13","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1021\/ac3029745","volume":"85","author":"GJ Patti","year":"2013","unstructured":"Patti GJ, Tautenhahn R, Rinehart D, Cho K, Shriver LP, Manchester M, et al. A view from above: cloud plots to visualize global metabolomic data. Anal Chem. 2013;85(2):798\u2013804.","journal-title":"Anal Chem"},{"issue":"3","key":"1655_CR14","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nchembio.767","volume":"8","author":"GJ Patti","year":"2012","unstructured":"Patti GJ, Yanes O, Shriver LP, Courade JP, Tautenhahn R, Manchester M, et al. Metabolomics implicates altered sphingolipids in chronic pain of neuropathic origin. Nat Chem Biol. 2012;8(3):232\u20134.","journal-title":"Nat Chem Biol"},{"issue":"10","key":"1655_CR15","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.autrev.2013.04.002","volume":"12","author":"R Priori","year":"2013","unstructured":"Priori R, Scrivo R, Brandt J, Valerio M, Casadei L, Valesini G, et al. Metabolomics in rheumatic diseases: the potential of an emerging methodology for improved patient diagnosis, prognosis, and treatment efficacy. Autoimmun Rev. 2013;12(10):1022\u201330.","journal-title":"Autoimmun Rev"},{"key":"1655_CR16","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1186\/1471-2105-12-366","volume":"12","author":"C Ludwig","year":"2011","unstructured":"Ludwig C, Gunther UL. MetaboLab\u2013advanced NMR data processing and analysis for metabolomics. BMC Bioinformatics. 2011;12:366.","journal-title":"BMC Bioinformatics"},{"key":"1655_CR17","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s11306-011-0347-7","volume":"8","author":"CEJ Ludwig","year":"2012","unstructured":"Ludwig CEJ, Lodi A, Tiziani S, Manzoor SE, et al. Birmingham metabolite library: a publicly accessible database of 1-D H-1 and 2-D H-1 J-resolved NMR spectra of authentic metabolite standards (BML-NMR). Metabolomics. 2012;8:8\u201318.","journal-title":"Metabolomics"},{"issue":"Database","key":"1655_CR18","doi-asserted-by":"publisher","first-page":"D521","DOI":"10.1093\/nar\/gkl923","volume":"35","author":"DS Wishart","year":"2007","unstructured":"Wishart DS, Tzur D, Knox C, Eisner R, Guo AC, Young N, et al. HMDB: the human metabolome database. Nucleic Acids Res. 2007;35(Database):D521\u20136.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"1655_CR19","doi-asserted-by":"publisher","first-page":"e000289","DOI":"10.1136\/rmdopen-2016-000289","volume":"2","author":"SR Sweeney","year":"2016","unstructured":"Sweeney SR, Kavanaugh A, Lodi A, Wang B, Boyle D, Tiziani S, et al. Metabolomic profiling predicts outcome of rituximab therapy in rheumatoid arthritis. RMD Open. 2016;2(2):e000289.","journal-title":"RMD Open"},{"issue":"1","key":"1655_CR20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/MOL.0000000000000259","volume":"27","author":"T Smallwood","year":"2016","unstructured":"Smallwood T, Allayee H, Bennett BJ. Choline metabolites: gene by diet interactions. Curr Opin Lipidol. 2016;27(1):33\u20139.","journal-title":"Curr Opin Lipidol"},{"key":"1655_CR21","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/cpbi.11","volume":"55","author":"J Xia","year":"2016","unstructured":"Xia J, Wishart DS. Using MetaboAnalyst 3.0 for comprehensive metabolomics data analysis. Curr Protoc Bioinformatics. 2016;55:14. 0 1\u20130 91","journal-title":"Curr Protoc Bioinformatics"},{"issue":"Web Server issu","key":"1655_CR22","doi-asserted-by":"publisher","first-page":"W652","DOI":"10.1093\/nar\/gkp356","volume":"37","author":"J Xia","year":"2009","unstructured":"Xia J, Psychogios N, Young N, Wishart DS. MetaboAnalyst: a web server for metabolomic data analysis and interpretation. Nucleic Acids Res. 2009;37(Web Server issue):W652\u201360.","journal-title":"Nucleic Acids Res"},{"issue":"Web Server issu","key":"1655_CR23","doi-asserted-by":"publisher","first-page":"W127","DOI":"10.1093\/nar\/gks374","volume":"40","author":"J Xia","year":"2012","unstructured":"Xia J, Mandal R, Sinelnikov IV, Broadhurst D, Wishart DS. MetaboAnalyst 2.0\u2013a comprehensive server for metabolomic data analysis. Nucleic Acids Res. 2012;40(Web Server issue):W127\u201333.","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"1655_CR24","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.mayocp.2017.05.009","volume":"92","author":"CA Wijbrandts","year":"2017","unstructured":"Wijbrandts CA, Tak PP. Prediction of response to targeted treatment in rheumatoid arthritis. Mayo Clin Proc. 2017;92(7):1129\u201343.","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"1655_CR25","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1136\/ard.2007.080440","volume":"67","author":"CA Wijbrandts","year":"2008","unstructured":"Wijbrandts CA, Dijkgraaf MG, Kraan MC, Vinkenoog M, Smeets TJ, Dinant H, et al. The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tumour necrosis factor alpha expression in the synovium. Ann Rheum Dis. 2008;67(8):1139\u201344.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"1655_CR26","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1002\/art.37921","volume":"65","author":"SR Kapoor","year":"2013","unstructured":"Kapoor SR, Filer A, Fitzpatrick MA, Fisher BA, Taylor PC, Buckley CD, et al. Metabolic profiling predicts response to anti-tumor necrosis factor alpha therapy in patients with rheumatoid arthritis. Arthritis Rheum. 2013;65(6):1448\u201356.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"1655_CR27","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1002\/art.39608","volume":"68","author":"R Garcia-Carbonell","year":"2016","unstructured":"Garcia-Carbonell R, Divakaruni AS, Lodi A, Vicente-Suarez I, Saha A, Cheroutre H, et al. Critical role of glucose metabolism in rheumatoid arthritis fibroblast-like synoviocytes. Arthritis Rheumatol. 2016;68(7):1614\u201326.","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"1655_CR28","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1136\/annrheumdis-2014-205696","volume":"74","author":"M Guma","year":"2015","unstructured":"Guma M, Sanchez-Lopez E, Lodi A, Garcia-Carbonell R, Tiziani S, Karin M, et al. Choline kinase inhibition in rheumatoid arthritis. Ann Rheum Dis. 2015;74(7):1399\u2013407.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"1655_CR29","first-page":"240","volume":"30","author":"T Hugle","year":"2012","unstructured":"Hugle T, Kovacs H, Heijnen IA, Daikeler T, Baisch U, Hicks JM, et al. Synovial fluid metabolomics in different forms of arthritis assessed by nuclear magnetic resonance spectroscopy. Clin Exp Rheumatol. 2012;30(2):240\u20135.","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"1655_CR30","doi-asserted-by":"publisher","first-page":"e97501","DOI":"10.1371\/journal.pone.0097501","volume":"9","author":"S Kim","year":"2014","unstructured":"Kim S, Hwang J, Xuan J, Jung YH, Cha HS, Kim KH. Global metabolite profiling of synovial fluid for the specific diagnosis of rheumatoid arthritis from other inflammatory arthritis. PLoS One. 2014;9(6):e97501.","journal-title":"PLoS One"},{"issue":"3","key":"1655_CR31","doi-asserted-by":"publisher","first-page":"e91769","DOI":"10.1371\/journal.pone.0091769","volume":"9","author":"MK Kosinska","year":"2014","unstructured":"Kosinska MK, Liebisch G, Lochnit G, Wilhelm J, Klein H, Kaesser U, et al. Sphingolipids in human synovial fluid\u2013a lipidomic study. PLoS One. 2014;9(3):e91769.","journal-title":"PLoS One"},{"issue":"1","key":"1655_CR32","doi-asserted-by":"publisher","first-page":"R19","DOI":"10.1186\/ar3243","volume":"13","author":"RK Madsen","year":"2011","unstructured":"Madsen RK, Lundstedt T, Gabrielsson J, Sennbro CJ, Alenius GM, Moritz T, et al. Diagnostic properties of metabolic perturbations in rheumatoid arthritis. Arthritis Res Ther. 2011;13(1):R19.","journal-title":"Arthritis Res Ther."},{"issue":"5","key":"1655_CR33","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrrheum.2016.1","volume":"12","author":"M Guma","year":"2016","unstructured":"Guma M, Tiziani S, Firestein GS. Metabolomics in rheumatic diseases: desperately seeking biomarkers. Nat Rev Rheumatol. 2016;12(5):269\u201381.","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"1655_CR34","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3109\/03009742.2016.1164242","volume":"46","author":"R Volchenkov","year":"2017","unstructured":"Volchenkov R, Dung Cao M, Elgstoen KB, Goll GL, Eikvar K, Bjorneboe O, et al. Metabolic profiling of synovial tissue shows altered glucose and choline metabolism in rheumatoid arthritis samples. Scand J Rheumatol. 2017;46(2):160\u20131.","journal-title":"Scand J Rheumatol"},{"key":"1655_CR35","doi-asserted-by":"crossref","unstructured":"Biniecka M, Canavan M, McGarry T, Gao W, McCormick J, Cregan S, Gallagher L, Smith T, Phelan JJ, Ryan J, O'sullivan J. Dysregulated bioenergetics: a key regulator of joint inflammation. Annals of the rheumatic diseases. 2016;75(12):2192-200.","DOI":"10.1136\/annrheumdis-2015-208476"},{"issue":"11","key":"1655_CR36","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1002\/art.11282","volume":"48","author":"A Roivainen","year":"2003","unstructured":"Roivainen A, Parkkola R, Yli-Kerttula T, Lehikoinen P, Viljanen T, Mottonen T, et al. Use of positron emission tomography with methyl-11C-choline and 2-18F-fluoro-2-deoxy-D-glucose in comparison with magnetic resonance imaging for the assessment of inflammatory proliferation of synovium. Arthritis Rheum. 2003;48(11):3077\u201384.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"1655_CR37","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s00441-014-2036-0","volume":"359","author":"J Beckmann","year":"2015","unstructured":"Beckmann J, Schubert J, Morhenn HG, Grau V, Schnettler R, Lips KS. Expression of choline and acetylcholine transporters in synovial tissue and cartilage of patients with rheumatoid arthritis and osteoarthritis. Cell Tissue Res. 2015;359(2):465\u201377.","journal-title":"Cell Tissue Res"},{"issue":"10","key":"1655_CR38","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1172\/JCI84431","volume":"126","author":"SE Corcoran","year":"2016","unstructured":"Corcoran SE, O\u2019Neill LA. HIF1alpha and metabolic reprogramming in inflammation. J Clin Invest. 2016;126(10):3699\u2013707.","journal-title":"J Clin Invest"},{"issue":"4","key":"1655_CR39","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.tibs.2014.02.004","volume":"39","author":"I Amelio","year":"2014","unstructured":"Amelio I, Cutruzzola F, Antonov A, Agostini M, Melino G. Serine and glycine metabolism in cancer. Trends Biochem Sci. 2014;39(4):191\u20138.","journal-title":"Trends Biochem Sci"},{"issue":"4","key":"1655_CR40","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.celrep.2014.04.045","volume":"7","author":"CF Labuschagne","year":"2014","unstructured":"Labuschagne CF, van den Broek NJ, Mackay GM, Vousden KH, Maddocks OD. Serine, but not glycine, supports one-carbon metabolism and proliferation of cancer cells. Cell Rep. 2014;7(4):1248\u201358.","journal-title":"Cell Rep"},{"issue":"1","key":"1655_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40170-015-0128-2","volume":"3","author":"CS Ahn","year":"2015","unstructured":"Ahn CS, Metallo CM. Mitochondria as biosynthetic factories for cancer proliferation. Cancer Metab. 2015;3(1):1.","journal-title":"Cancer Metab"},{"issue":"2","key":"1655_CR42","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.cmet.2016.12.011","volume":"25","author":"EH Ma","year":"2017","unstructured":"Ma EH, Bantug G, Griss T, Condotta S, Johnson RM, Samborska B, et al. Serine is an essential metabolite for effector T cell expansion. Cell Metab. 2017;25(2):345\u201357.","journal-title":"Cell Metab"},{"issue":"5","key":"1655_CR43","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/ni.3704","volume":"18","author":"EL Mills","year":"2017","unstructured":"Mills EL, Kelly B, O'Neill LAJ. Mitochondria are the powerhouses of immunity. Nat Immunol. 2017;18(5):488\u201398.","journal-title":"Nat Immunol"},{"issue":"1","key":"1655_CR44","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.tem.2013.09.002","volume":"25","author":"JC Newman","year":"2014","unstructured":"Newman JC, Verdin E. Ketone bodies as signaling metabolites. Trends Endocrinol Metab. 2014;25(1):42\u201352.","journal-title":"Trends Endocrinol Metab"},{"issue":"6116","key":"1655_CR45","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1126\/science.1227166","volume":"339","author":"T Shimazu","year":"2013","unstructured":"Shimazu T, Hirschey MD, Newman J, He W, Shirakawa K, Le Moan N, et al. Suppression of oxidative stress by beta-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science. 2013;339(6116):211\u20134.","journal-title":"Science"},{"issue":"3","key":"1655_CR46","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nm.3804","volume":"21","author":"YH Youm","year":"2015","unstructured":"Youm YH, Nguyen KY, Grant RW, Goldberg EL, Bodogai M, Kim D, et al. The ketone metabolite beta-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nat Med. 2015;21(3):263\u20139.","journal-title":"Nat Med"},{"key":"1655_CR47","first-page":"532","volume":"7","author":"Y Li","year":"2016","unstructured":"Li Y, Zheng JY, Liu JQ, Yang J, Liu Y, Wang C, et al. Succinate\/NLRP3 Inflammasome induces synovial fibroblast activation: therapeutical effects of clematichinenoside AR on arthritis. Front Immunol. 2016;7:532.","journal-title":"Front Immunol"},{"issue":"5","key":"1655_CR48","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.tcb.2013.11.008","volume":"24","author":"E Mills","year":"2014","unstructured":"Mills E, O\u2019Neill LA. Succinate: a metabolic signal in inflammation. Trends Cell Biol. 2014;24(5):313\u201320.","journal-title":"Trends Cell Biol"},{"issue":"6","key":"1655_CR49","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.cell.2013.05.016","volume":"153","author":"CH Chang","year":"2013","unstructured":"Chang CH, Curtis JD, Maggi LB Jr, Faubert B, Villarino AV, O'Sullivan D, et al. Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell. 2013;153(6):1239\u201351.","journal-title":"Cell"},{"key":"1655_CR50","doi-asserted-by":"crossref","unstructured":"Yu X, Li S. Non-metabolic functions of glycolytic enzymes in tumorigenesis. Oncogene. 2017;36(19):2629.","DOI":"10.1038\/onc.2016.410"},{"issue":"7","key":"1655_CR51","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1021\/ac0517085","volume":"78","author":"M-E Dumas","year":"2006","unstructured":"Dumas M-E, Maibaum EC, Teague C, Ueshima H, Zhou B, Lindon JC, et al. Assessment of analytical reproducibility of 1H NMR spectroscopy based metabonomics for large-scale epidemiological research: the INTERMAP study. Anal Chem. 2006;78(7):2199\u2013208.","journal-title":"Anal Chem"},{"issue":"1","key":"1655_CR52","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1021\/es802198z","volume":"43","author":"MR Viant","year":"2008","unstructured":"Viant MR, Bearden DW, Bundy JG, Burton IW, Collette TW, Ekman DR, et al. International NMR-based environmental metabolomics intercomparison exercise. Environ Sci Technol. 2008;43(1):219\u201325.","journal-title":"Environ Sci Technol"},{"issue":"7","key":"1655_CR53","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1039\/c000091d","volume":"135","author":"S Zhang","year":"2010","unstructured":"Zhang S, Nagana Gowda GA, Ye T, Raftery D. Advances in NMR-based biofluid analysis and metabolite profiling. Analyst. 2010;135(7):1490\u20138.","journal-title":"Analyst"},{"issue":"3","key":"1655_CR54","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.trac.2007.12.001","volume":"27","author":"DS Wishart","year":"2008","unstructured":"Wishart DS. Quantitative metabolomics using NMR. TrAC Trends Anal Chem. 2008;27(3):228\u201337.","journal-title":"TrAC Trends Anal Chem"},{"issue":"4","key":"1655_CR55","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1079\/BJN20041243","volume":"92","author":"PD Whitfield","year":"2004","unstructured":"Whitfield PD, German AJ, Noble PJM. Metabolomics: an emerging post-genomic tool for nutrition. Br J Nutr. 2004;92(4):549\u201355.","journal-title":"Br J Nutr"},{"issue":"9","key":"1655_CR56","doi-asserted-by":"publisher","first-page":"e73076","DOI":"10.1371\/journal.pone.0073076","volume":"8","author":"S Bouatra","year":"2013","unstructured":"Bouatra S, Aziat F, Mandal R, Guo AC, Wilson MR, Knox C, et al. The human urine metabolome. PLoS One. 2013;8(9):e73076.","journal-title":"PLoS One"},{"issue":"12","key":"1655_CR57","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nrrheum.2016.175","volume":"12","author":"PM Brown","year":"2016","unstructured":"Brown PM, Pratt AG, Isaacs JD. Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkers. Nat Rev Rheumatol. 2016;12(12):731\u201342.","journal-title":"Nat Rev Rheumatol"},{"key":"1655_CR58","doi-asserted-by":"crossref","unstructured":"Jubair WK, Hendrickson JD, Severs EL, Schulz HM, Adhikari S, Ir D, et al. Modulation of inflammatory arthritis by gut microbiota through mucosal inflammation and autoantibody generation. Arthritis Rheumatol. 2018.","DOI":"10.1002\/art.40490"},{"issue":"11","key":"1655_CR59","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1002\/art.39783","volume":"68","author":"Y Maeda","year":"2016","unstructured":"Maeda Y, Kurakawa T, Umemoto E, Motooka D, Ito Y, Gotoh K, et al. Dysbiosis contributes to arthritis development via activation of autoreactive T cells in the intestine. Arthritis Rheumatol. 2016;68(11):2646\u201361.","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"1655_CR60","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/nrrheum.2011.121","volume":"7","author":"JU Scher","year":"2011","unstructured":"Scher JU, Abramson SB. The microbiome and rheumatoid arthritis. Nat Rev Rheumatol. 2011;7(10):569\u201378.","journal-title":"Nat Rev Rheumatol"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1655-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-018-1655-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1655-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T13:57:13Z","timestamp":1589551033000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-018-1655-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,3]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1655"],"URL":"https:\/\/doi.org\/10.1186\/s13075-018-1655-3","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,3]]},"assertion":[{"value":"19 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Patients were enrolled in the ARISE clinical trial following written informed consent. Ethical approval was granted by the Institutional Review Board (IRB) at UCSD.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/A","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that thet have no competing interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"164"}}